Skip to Main Content Area
Atlantic Provinces Pediatric Hematology Oncology Network
About Us
Contact
Email Updates
News & Events
Levels of Care
Guidelines
Education
Atlantic Canada Oncofertility
Conference Updates
Links
COVID-19
Educational Sessions
Blinatumomab Education
Chemotherapy Information
Chemotherapy Administration
Coping & Distraction Techniques
CVADs
Febrile Neutropenia
Kitelock Trial
Sickle Cell/Asplenia Review
Vaccination Guidelines
Home
»
Education
»
Kitelock Trial
Kitelock Trial
IWK Health, Hematology/Oncology/Nephrology, started the kitelock trial on October 14th, 2026. Please see the following guidelines:
Kitelock (Edetate 4%) Locking Solution CVAD Trial
From CHEO Research Institute:
Breaking the Chain of Infection: KiteLock as a Strategy to Reduce Central Line Associated Bloodstream Infections